This video examines findings from the International Breast Cancer Intervention Study (IBIS-1), which found that patients with menopause symptoms were less likely to continue long-term tamoxifen therapy.
Samuel Smith, PhD
Advertisement
Articles by Samuel Smith, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC
3
IMNN-001 Plus Neoadjuvant Chemo Improves OS in Advanced Ovarian Cancer
4
Nadofaragene Firadenovec Label Update Approved in BCG-Unresponsive NMIBC
5